Evidence map›Paper›PMID 33062701›Full record

ArticleBioMed research international2020

Platelet-Rich Plasma Combined with Alendronate Reduces Pain and Inflammation in Induced Osteoarthritis in Rats by Inhibiting the Nuclear Factor-Kappa B Signaling Pathway.

Feng Xin, Haihong Wang, Feng Yuan, Yunzhi Ding

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2021
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Experimental Therapeutics for the Treatment of Osteoarthritis.Journal of experimental pharmacology · 2021
    Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Feng XinDepartment of Orthopaedics, Xuzhou Cancer Hospital, No. 131, Huancheng Road, Xuzhou City, Jiangsu Province 221000, China.
Haihong WangDepartment of Hepatobiliary Surgery, Xuzhou Cancer Hospital, No. 131, Huancheng Road, Xuzhou City, Jiangsu Province 221000, China.
Feng YuanDepartment of Orthopaedics, Affiliated Hospital of Xuzhou Medical University, No. 99, West Huaihai Road, Xuzhou City, Jiangsu Province 221000, China.ORCID https://orcid.org/0000-0002-6455-6417
Yunzhi DingDepartment of Orthopaedics, Xuzhou Cancer Hospital, No. 131, Huancheng Road, Xuzhou City, Jiangsu Province 221000, China.ORCID https://orcid.org/0000-0001-5254-0488
Jiangsu University · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOsteoarthritis (OA) is one of the common degenerative diseases of the joint in the world. This study was designed to explore the effect of platelet-rich plasma (PRP) combined with alendronate (ALN) on OA.

methodsWe induced OA model by anterior cruciate ligament transection (ACLT) method in rats and treating chondrocytes by IL-1

resultsTreatment with PRP, ALN, or PRP combined with ALN decreased the degree of cartilage destruction, the mRNA expression of MMP-13 and inflammatory factors (IL-18, IL-1

conclusionPRP combined with ALN delayed OA progression by inhibiting the NF-

Indexed as

Platelet-Rich PlasmaAlendronateAnimalsArthralgiaBone Density Conservation AgentsCells, CulturedChondrocytesDisease Models, AnimalInflammationNF-kappa BOsteoarthritisRatsRats, Sprague-DawleySignal TransductionAlendronateBone Density Conservation AgentsNF-kappa B

Identifiers

PMID33062701
PMCPMC7539111
OpenAlexW3088647721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.